OKYO Pharma Ltd (OKYO) KPIs and segments

OKYONasdaqBiological Products, (No Diagnostic Substances)

Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jul 20, 2026Score 1/30

$1.40−0.02 (-1.41%)

Close on Nov 12, 2026Market cap $73.47MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive OKYO Pharma's business

Coming soon

This tab will track the numbers specific to OKYO Pharma's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?